The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1302-1305, October 2004

SERUM PROTEOMIC PROFILING CAN DISCRIMINATE PROSTATE CANCER FROM BENIGN PROSTATES IN MEN WITH TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2.5 AND 15.0 NG/ML

From the Lineberger Comprehensive Cancer Center, University of North Carolina (DKO), Chapel Hill, North Carolina, Department of Urology, Louisiana State University (WR), New Orleans, Louisiana, and Clinical Proteomics Program, Food and Drug Administration/National Institutes of Health (VAF, TPC, SJR, TDV, LAL, EFP) and Correlogic Systems (BAH, WWW), Bethesda, Maryland

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Accepted for publication May 21, 2004.Study received institutional review board approval.

PII: S0022-5347(05)61156-1

doi:10.1097/01.ju.0000139572.88463.39

The Journal of Urology
Volume 172, Issue 4, Part 1 , Pages 1302-1305, October 2004

Article Tools

* Image Usage & Resolution